BioCentury
ARTICLE | Clinical News

DNA-based vaccine containing the code for Herpes simplex viral protein gD2: Phase I testing

September 30, 1996 7:00 AM UTC

Apollon Inc., Malvern, Penn. Product: DNA-based vaccine containing the code for Herpes simplex viral protein gD2 Indication: Genital herpes, primarily herpes simplex virus-2, but possibly also HSV-1 S...